Cargando…
Synthetic Biology, Directed Evolution, and the Rational Design of New Cardiovascular Therapeutics: Are We There Yet?
Autor principal: | Mann, Douglas L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10401280/ https://www.ncbi.nlm.nih.gov/pubmed/37547074 http://dx.doi.org/10.1016/j.jacbts.2023.06.003 |
Ejemplares similares
-
Are Synthetic Data Derivatives the Future of Translational Medicine?
por: Foraker, Randi, et al.
Publicado: (2018) -
Now That We Have an Effective Vaccine for COVID-19, Will It Also Inoculate Us Against the Virus of Indifference?
por: Mann, Douglas L.
Publicado: (2021) -
Potential Effect of Brexit on Cardiovascular Translational Science
por: Shah, Ajay M., et al.
Publicado: (2016) -
Will the Precision Medicine Initiative Transform Cardiovascular Translational Research?
por: Mann, Douglas L., et al.
Publicado: (2016) -
The Rising Cost of Developing Cardiovascular Therapies and Reproducibility in Translational Research: Do Not Blame It (All) on the Bench
por: Mann, Douglas L.
Publicado: (2017)